In a new study led by researchers at Geisinger Obesity Institute in Danville, Pennsylvania, investigators were surprised when they saw overwhelming evidence that weight-loss surgery decreased long-term risks of heart failure by more than half in…

New research presented at the American Thoracic Society conference in San Francisco has provided evidence that people with chronic obstructive pulmonary disease (COPD) or have a history or risk for cardiovascular disease more often suffer from…

Researchers from Linkoping University in Sweden have developed a tablet device that can help treat heart failure patients, reports DNA.

The tablet, called OPTILOGG, is a pre-programmed device attached to a weighing scale that can…

The American Heart Association (AHA) announced May 17 the launch of four research projects all focused on examining heart disease in women.

The projects will be funded by a $5 million donation given to the AHA’s subsidiary Go Red For Women…

New research shows that postmenopausal women who reached menopause at an earlier age or who never gave birth at all are at a higher risk for developing heart failure.

The…

Lancaster General Hospital has lowest Medicare heart failure readmission rate in the U.S., according to government statistics. How this facility managed to become a leader in the field has to do with patient engagement.

But change didn’t…

Being unemployed could have deadly consequences for patients suffering from heart failure, a new study finds.

The…

A new scientific statement published by the American Heart Association (AHA) suggests that innovative biomarker tests for heart failure could help physicians better diagnose and treat the condition.

The…

American Regent announced on April 24 that the first patients had enrolled in a phase 3 trial evaluating an investigational heart failure medication.

During the study,…

The FDA determined that Medtronic’s voluntary recall of its HVAD system controllers and DC adapters was a class I recall, according to a Medtronic news release on April 18.

Medtronic had previously announced field safety notices related to…

New research has found that being in a city where a major marathon is being hosted can increase the risk of heart attack and cardiac arrest, reports Reuters.

The study authors believe the increases are a result of blocked streets…

Endotronix recently announced it had recently hired several executives to join its management team.

Katrin Leadley, MD, joins Endotronix as chief…

New research from Newcastle University found the use of left ventricular assist devices (LVADs) combined with medication can fully restore heart function in patients with end stage heart failure, a major breakthrough for heart failure patients…

At six months, patients with advanced heart failure who were implanted with the HeartMate 3 left ventricular assist system were less likely to have hemocompatibility- related clinical adverse events (HRAEs) compared with those who received the…

New research from the University of Gothenburg in Sweden has suggested that bigger women, classified as those who are taller than average and are overweight, could be at a greater risk of atrial fibrillation (AFib).

The study, which…

Researchers from Case Western Reserve University have found a new target for drug developers looking for ways to improve cardiac function in heart failure patients.

The study,…

New research from the University of Pennsylvania shows that patients with severe heart failure have higher levels of thyroid hormones, which can be responsible for causing atrial fibrillation.

The study was presented April 2 at ENDO 2017,…

A person's unique genetic makeup may mean greater chances of certain harmful conditions, but other times, one's genes can actually be a defense against negative health outcomes. New research from…

New research from China has found insomnia can be a cause for an increased risk in having a heart attack or stroke, a finding that can help cardiologists better predict a patient’s risk for experiencing an adverse cardiac event.

The…

Novartis announced that a phase 3 study evaluating the company’s investigational heart failure medication (serelaxin) did not meet its primary endpoint.

Results of the RELAX-AHF-2 study…

Medicare beneficiaries who received an implantable pulmonary artery pressure (PAP) sensor had a statistically significant 45 percent lower rate of heart failure hospitalizations and reduced costs at six months, according to a retrospective cohort…